BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Naming MacMahon CEO, Mitralign, Inc. Raises Additional $3 Million Series B


4/21/2006 10:52:01 AM

4/21/2006 – On the heels of tapping John MacMahon as chief executive, cardiac device developer Mitralign Inc. has closed its Series B round at $13 million with an additional $3 million tranche, VentureWire has learned.

MacMahon comes to Mitralign from Kerberos Proximal Solutions Inc., where he served as president and CEO and which he co-founded in 2001 as a graduate student. He takes over for Rick Geoffrion, chairman of Mitralign, who had been filling in since the August 2005 departure of CEO Donald Webber.

Based in Tewksbury, Mass., Mitralign is developing a catheter to place sutures around the mitral valve of the heart and cinch them to prevent leakage.

Mitralign has raised $18 million, including a $13 million Series B round led by Oxford Bioscience Partners and joined by ABN Amro Capital, Giza Venture Capital, Accelerated Technologies, and Triathlon Medical Ventures.




   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->